Cancer Research Foundation

Recent papers from Cancer Research Foundation

1. Gene dosage imbalance disrupts systemic metabolism in the Dp16 Down syndrome mouse modeleLife · 2026
2. Melanoma of unknown primary: UV-driven genomics and the need for era-adjusted outcomesBritish Journal of Dermatology · 2026
3. Therapy-related myeloid neoplasms after radioligand therapy in neuroendocrine tumors: A multicenter real-world analysis.Journal of Clinical Oncology · 2026
4. Development and early implementation of a statewide comprehensive childhood cancer network to support pediatric oncology care and research.Journal of Clinical Oncology · 2026
5. Gender representation in international cancer research funding.2026
6. Cellular neighborhoods govern antitumor T-cell infiltration following anti-CTLA-4 in melanoma with primary resistance to anti-PD-1Cancer Discovery · 2026
7. Abstract CT139: Germline HFE mutations predict for durable response to arginine depletion with pegargiminase-based chemotherapy in pleural mesotheliomaCancer Research · 2026
8. Abstract 2514: Patient-driven multi-omic longitudinal research study reveals novel insights into uveal melanoma progressionCancer Research · 2026
9. Gene dosage imbalance disrupts systemic metabolism in the Dp16 Down syndrome mouse modeleLife · 2026
10. Life cycle assessment approach for upcycling expanded polystyrene across industrial sectorsCircular Economy · 2026
11. HPV Vaccination in Nigeria: Lessons and Recommendations From the Successes of HPV Vaccination in the United StatesNigerian Journal of Oncology · 2026
12. Swallowing characteristics in Down syndrome at an advanced age: a preclinical study in the Ts65Dn mouse modelFrontiers in Neurology · 2026
13. Online patient and caregiver conversations focused on neuroendocrine neoplasms (NENs): A global thematic analysis.Journal of Clinical Oncology · 2026
14. Determining the Cancer Center Priorities at the Wilmot Cancer Institute: A Proposed Framework Informed by an Academic-Community Collaborative ApproachThe Oncologist · 2025
15. Ten-year survival rates by PSA nadir in patients with metastatic hormone-sensitive prostate cancer: long-term survival analysis from the ECOG-ACRIN 3805 (CHAARTED) trialAnnals of Oncology · 2025
16. Mortality and relapse dynamics in AML after three years of complete remissionLeukemia & lymphoma/Leukemia and lymphoma · 2025
17. Clinical and dermoscopic assessment of angiosarcoma: a diagnostic classification for early detectionDermatology Reports · 2025
18. The American Federation for Medical Research maintains commitment to decades of support of vaccine and vaccination research to improve public healthJournal of Investigative Medicine · 2025
19. Real-world holistic care for adult cancer survivors and their families: improved family dynamics and positive outlookAcademia Mental Health and Well-Being · 2025
20. Bone Marrow Failure Associated With Short Telomeres and Digenic Variants of Uncertain Significance in Telomere Biology GenesCase Reports in Genetics · 2025